{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:42:49Z","timestamp":1770982969507,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.pcd.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T03:08:14Z","timestamp":1686625694000},"page":"506-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sensitivity and specificity of three diabetes diagnostic criteria in people with non-alcoholic fatty liver disease (NAFLD) and otherwise healthy people: Analysis of NHANES III"],"prefix":"10.1016","volume":"17","author":[{"given":"Rodrigo M.","family":"Carrillo-Larco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilmer Cristobal","family":"Guzman-Vilca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-7997","authenticated-orcid":false,"given":"Claudia","family":"Alvizuri-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Garc\u00eda-Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2023.06.003_bib1","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","author":"Le","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"5","key":"10.1016\/j.pcd.2023.06.003_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.pcd.2023.06.003_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100706","article-title":"Non-alcoholic fatty liver disease prevalence in Latin America: a systematic review and meta-analysis","author":"Rojas","year":"2022","journal-title":"Ann. Hepatol."},{"issue":"12","key":"10.1016\/j.pcd.2023.06.003_bib4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S2468-1253(21)00275-2","article-title":"Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa","volume":"6","author":"Spearman","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.pcd.2023.06.003_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DMSO.S146339","article-title":"Obesity and nonalcoholic fatty liver disease: current perspectives","volume":"11","author":"Sarwar","year":"2018","journal-title":"Diabetes, Metab. Syndr. Obes.: Targets Ther."},{"issue":"5","key":"10.1016\/j.pcd.2023.06.003_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol. (Baltim., Md)"},{"issue":"12","key":"10.1016\/j.pcd.2023.06.003_bib7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40273-015-0316-5","article-title":"Economic and quality-of-life implications of non-alcoholic fatty liver disease","volume":"33","author":"Younossi","year":"2015","journal-title":"PharmacoEconomics"},{"issue":"7","key":"10.1016\/j.pcd.2023.06.003_bib8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.cgh.2019.10.023","article-title":"Health care costs of patients with biopsy-confirmed nonalcoholic fatty liver disease are nearly twice those of matched controls","volume":"18","author":"Hagstr\u00f6m","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"10027","key":"10.1016\/j.pcd.2023.06.003_bib9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"issue":"10258","key":"10.1016\/j.pcd.2023.06.003_bib10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet (Lond., Engl.)"},{"issue":"10258","key":"10.1016\/j.pcd.2023.06.003_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.pcd.2023.06.003_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108072","article-title":"Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"162","author":"Williams","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.pcd.2023.06.003_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"39","key":"10.1016\/j.pcd.2023.06.003_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008179","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis","volume":"96","author":"Dai","year":"2017","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.pcd.2023.06.003_bib15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.pcd.2023.06.003_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","article-title":"Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.pcd.2023.06.003_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/1753-0407.13138","article-title":"The impact of ferritin on the disassociation of HbA1c and mean plasma glucose","volume":"13","author":"Li","year":"2021","journal-title":"J. Diabetes"},{"issue":"3","key":"10.1016\/j.pcd.2023.06.003_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1746.2010.06528.x","article-title":"Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease","volume":"26","author":"Manchanayake","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.pcd.2023.06.003_bib19","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.pcd.2023.06.003_bib20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.pcd.2023.06.003_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2023.06.003_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltim. Md)"},{"issue":"12","key":"10.1016\/j.pcd.2023.06.003_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis.: Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"issue":"Suppl 1","key":"10.1016\/j.pcd.2023.06.003_bib24","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Mahfood Haddad","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.pcd.2023.06.003_bib25","unstructured":"National Health and Nutrition Examination Survey. 1988\u20131994 Data Documentation, Codebook, and Frequencies. Hepatic\/Gallbladder Ultrasound and Hepatic Steatosis (HGUHS). Available at: \u3008https:\/\/wwwn.cdc.gov\/nchs\/data\/nhanes3\/34a\/HGUHS.htm\u3009 (Accessed May 18th, 2022)."},{"issue":"1","key":"10.1016\/j.pcd.2023.06.003_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatol. (Baltim., Md)"},{"key":"10.1016\/j.pcd.2023.06.003_bib27","unstructured":"Centers for Disease Control and Prevention. NHANES III - Laboratory Data File. Available at: \u3008https:\/\/wonder.cdc.gov\/wonder\/sci_data\/surveys\/hanes\/hanes3\/type_txt\/lab.asp\u3009 (Accessed May 18th 2022)."},{"issue":"Suppl 1","key":"10.1016\/j.pcd.2023.06.003_bib28","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes care"},{"issue":"4","key":"10.1016\/j.pcd.2023.06.003_bib29","first-page":"771","article-title":"Adiposity as a risk factor of non alcoholic fat disease; systematic review","volume":"29","author":"Jim\u00e9nez-Cruz","year":"2014","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.pcd.2023.06.003_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ypmed.2017.01.012","article-title":"Is waist circumference \u2265102\/88cm better than body mass index \u226530 to predict hypertension and diabetes development regardless of gender, age group, and race\/ethnicity? Meta-analysis","volume":"97","author":"Seo","year":"2017","journal-title":"Prev. Med."},{"issue":"1","key":"10.1016\/j.pcd.2023.06.003_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.20506\/rst.40.1.3224","article-title":"Bayesian latent class analysis when the reference test is imperfect","volume":"40","author":"Cheung","year":"2021","journal-title":"Rev. Sci. Technol."},{"issue":"6","key":"10.1016\/j.pcd.2023.06.003_bib32","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1177\/1932296814538774","article-title":"Effects of hemoglobin variants on hemoglobin a1c values measured using a high-performance liquid chromatography method","volume":"8","author":"Lorenzo-Medina","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"7","key":"10.1016\/j.pcd.2023.06.003_bib33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes","volume":"27","author":"Goldstein","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2023.06.003_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology (Baltim., Md)"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991823001067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991823001067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:01:49Z","timestamp":1761696109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991823001067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1751991823001067"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2023.06.003","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitivity and specificity of three diabetes diagnostic criteria in people with non-alcoholic fatty liver disease (NAFLD) and otherwise healthy people: Analysis of NHANES III","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.","name":"copyright","label":"Copyright"}]}}